2024-11-13 REL RCSB RCSB RCSB 2020-10-09 2021-03-17 2021-03-17 2024-11-13 HCMV prefusion gB in complex with fusion inhibitor WAY-174865 Liu Y Heim PK fusogen, prefusion, HCMV, gB, antibody, VIRAL PROTEIN, fusion inhibitor, VIRAL PROTEIN-INHIBITOR complex Liu Y Heim KP Che Y Chi X Qiu X Han S Dormitzer PR Yang X Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Sci Adv US 7 2021 33674318 doi:10.1126/sciadv.abf3178 2375-2548 7kdp FULLOVERLAP HCMV prefusion gB stabilized by a fusion inhibitor HCMV prefusion gB stabilized by a fusion inhibitor 0 1
SM5-1 FAb is recombinant expressed with 6xHis and Strep sequence at C-terminal as purification tags. The FAb was used to purify the gB protein from lab cultured HCMV virus (Towne strain)In the density map, the FAb is poorly resolved and not modeled
Human cytomegalovirus (strain Towne) Towne 0.3 Envelope glycoprotein B Human cytomegalovirus (strain Towne) Towne 0.10206768799999999 3 LEVO MESRIWCLVVCVNLCIVCLGAAVSSSSTRGTSATHSHHSSHTTSAAHSRSGSVSQRVTSSQTVSHGVNETIYNTTLKYGD VVGVNTTKYPYRVCSMAQGTDLIRFERNIVCTSMKPINEDLDEGIMVVYKRNIVAHTFKVRVYQKVLTFRRSYAYIHTTY LLGSNTEYVAPPMWEIHHINSHSQCYSSYSRVIAGTVFVAYHRDSYENKTMQLMPDDYSNTHSTRYVTVKDQWHSRGSTW LYRETCNLNCMVTITTARSKYPYHFFATSTGDVVDISPFYNGTNRNASYFGENADKFFIFPNYTIVSDFGRPNSALETHR LVAFLERADSVISWDIQDEKNVTCQLTFWEASERTIRSEAEDSYHFSSAKMTATFLSKKQEVNMSDSALDCVRDEAINKL QQIFNTSYNQTYEKYGNVSVFETTGGLVVFWQGIKQKSLVELERLANRSSLNLTHNRTKRSTDGNNATHLSNMESVHNLV YAQLQFTYDTLRGYINRALAQIAEAWCVDQRRTLEVFKELSKINPSAILSAIYNKPIAARFMGDVLGLASCVTINQTSVK VLRDMNVKESPGRCYSRPVVIFNFANSSYVQYGQLGEDNEILLGNHRTEECQLPSLKIFIAGNSAYEYVDYLFKRMIDLS SISTVDSMIALDIDPLENTDFRVLELYSQKELRSSNVFDLEEIMREFNSYKQRVKYVEDKVVDPLPPYLKGLDDLMSGLG AAGKAVGVAIGAVGGAVASVVEGVATFLKNPFGAFTIILVAIAVVIIIYLIYTRQRRLCMQPLQNLFPYLVSADGTTVTS GNTKDTSLQAPPSYEESVYNSGRKGPGPPSSDASTAAPPYTNEQAYQMLLALVRLDAEQRAQQNGTDSLDGQTGTQDKGQ KPNLLDRLRHRKNGYRHLKDSDEEENV P13201 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 30 NAG N-{4-[({(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}carbamothioyl)amino]phenyl}-1,3-thiazole-4-carboxamide 0.000518498 3 WCY CALCIUM ION 4.0078e-05 1 CA singleParticle particle 0.8 7.4
PBS, 0.1 % DDM, 1 mM EDTA, 2 mg/L WAY-174865
 Quantifoil R1.2/1.3 COPPER 300 GRAPHENE OXIDE CONTINUOUS GLOW DISCHARGE AIR ETHANE 100 277 FEI VITROBOT MARK II
4 second, -2 force.
this sample was monodispersed
 FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 70.0 2.7 0.8 2.8000000000000003 18000.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN GATAN K2 SUMMIT (4k x 4k) SUPER-RESOLUTION 1-28 3 7768 40.0 1
the movies are motion corrected dose weighted and averaged with and binned 2x in Fourier space with MotionCor2 program
1906220
a 20 angstrom low pass filtered postfusion structure was used to generate reference images for the particle auto picking
 5CXF 1 C3 BACK PROJECTION 3.6 FSC 0.143 CUT-OFF RELION 2.1 beta 129837 PROJECTION MATCHING 7.5 RELION 2.1 beta PROJECTION MATCHING 1.8 RELION 2.1 beta 5 129837.0 RELION 2.1 beta emd_22828.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 280 280 280 0 0 0 280 280 280 385.28 385.28 385.28 90.0 90.0 90.0 X Y Z -0.18670075 0.31882638 0.00031225433 0.0054186704 1.376 1.376 1.376 0.05 AUTHOR HCMV gB in prefusion conformation 5CXF PDB experimental model FLEXIBLE FIT REAL